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Introduction
Affecting one in 500 persons, hypertrophic cardiomyopathy (HCM) is a disease associated with remarkable genotypic and phenotypic heterogeneity [1, 2] . Clinical outcomes range from an entirely asymptomatic course with normal longevity to chronic progressive heart failure or sudden cardiac death (SCD). Indeed, HCM is one of the leading causes of SCD in young persons [1] .
The most common genetically mediated form of HCM is myofilament-HCM with hundreds of disease-associated mutations in 8 genes encoding proteins critical to the sarcomere's thick -[ -myosin heavy chain (MYH7) [3] , regulatory myosin light chain (MYL2) and essential myosin light chain (MYL3)] [4] , intermediate -[myosin binding protein C (MYBPC3)] [5] , and thin myofilament [cardiac troponin T (TNNT2), -tropomyosin (TPM1) [6] , cardiac troponin I (TNNI3) [7] , and actin (ACTC) [8, 9] ].
Myofilament-HCM accounts for approximately 40-65% of HCM among cohorts of unrelated patients [10] . In general, patients with myofilament-HCM have greater hypertrophy and present at a younger age than those who remain without an established disease-causing mutation [11] . The 2 most common genotypes of myofilament-HCM, MYBPC3-and MYH7-HCM, are phenotypically indistinguishable from each other [12, 13, 14, 15, 16, 17, 18, 19, 20] .
Besides perturbations involving the sarcomere's myofilaments, the Z-disc, which comprises a cadre of proteins involved in cardiomyocyte cytoarchitecture and mechano-sensor-signaling, has emerged recently as host to several HCM-associated mutations extending the spectrum of "sarcomeric"-HCM. To date, 3 genes encoding critical Z-disc proteins: TTN-encoded titin, CSRP3-encoded muscle LIM protein (MLP), and the TCAP-encoded telethonin, have been implicated in the pathogenesis of both dilated cardiomyopathy (DCM) and HCM [21, 22, 23, 24] .
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As part of the cardiomyocyte stretch response machinery, TTN-encoded titin, which extends throughout half of the sarcomere from the M-line to the Z-disc is the largest of the three proteins; mapped on chromosome 2q31, TTN encodes for a giant 26,926 amino-acid protein with a molecular weight of 2,993 kD [25] . CSRP3-encoded MLP and TCAP-encoded telethonin are mapped to 11p15.1 and 17q12 respectively and contain 194 and 167 amino acids respectively [26, 27] . Prior to this study, 1 HCMassociated mutation in TTN (R740L-TTN) [28] , 3 HCM-associated mutations in MLP (L44P-MLP, C58G-MLP and S54R/E55G-MLP) [22] , and 2 HCM-associated mutations in TCAP (T137I-TCAP and R153H-TCAP) have been reported [21] .
Having completed a comprehensive mutational analysis involving all translated exons of the 8 genes responsible for myofilament-HCM [14, 15, 29, 30] , we sought to determine the frequency, spectrum, and phenotype associated with these 3 genes that encode essential Z-disc proteins among a large cohort of unrelated patients diagnosed clinically with HCM.
Methods

Study population
Following a written informed consent for this IRB-approved research protocol, blood samples were obtained from 389 unrelated patients with HCM (215 male, left ventricular wall thickness of 21.6 6 mm) evaluated at the Mayo Clinic's HCM clinic between April 1997 and December 2001. Subsequently DNA was extracted from the blood samples using Purgene DNA extraction kits (Gentra, Minneapolis, Minnesota).
HCM-associated mutational analysis of TTN, CSRP3, and TCAP
Using polymerase chain reaction (PCR) and denaturing high performance liquid Figure 1 . Primers, annealing temperatures and optimized WAVE conditions are available upon request. Four hundred reference alleles, derived from 100 white and 100 black healthy controls (Coriell Cell Repositories), were also examined to determine whether an identified amino acid variant was a common polymorphism. The non-synonymous mutations were annotated using the single letter convention as in L44P whereby the wild type leucine (L) at residue 44 has been replaced by proline (P).
Statistical analysis
Analysis of variance tests were used to assess differences between continuous variables; contingency tables or z-tests were used as appropriate to analyze nominal variables independency of the different variables. Student's T-tests were performed to elucidate differences between the different subgroups. A p-value less than 0.05 was considered statistically significant. (12), and TCAP (4). The clinical phenotypes of these patients are described in Table 2 . The average at diagnosis for MLP (CSRP3) -and TCAP-associated HCM was 48.5 ± 17 and 38.8 ± 9 years, respectively, while the mean maximal left ventricular wall thickness (MLVWT) was 20.1 ± 3 mm and 29.5 ± 12 mm, respectively. Three patients (25%) with a MLP-mutation and 1 patient (25%) with a TCAP-mutation reported a family history of HCM, while 2 and 1 patient (17 and 25%) respectively had a family history of SCD. A total of 8 patients underwent a surgical myectomy due to refractory symptoms despite optimal medical treatment. 
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Clinical phenotypes are described in Table 2 . K42fs/165 and Q91L were detected in patients having no HCM-associated myofilament mutations (cases 8 and 12). The previously published HCM-causing mutation (L44P, case 9) localized to the LIM1 -actinin binding domain while the R64C and Y66C mutations (cases 10 and 11) localized to the 6 amino acid nuclear localization signal (NLS). These 3 mutations (cases 9-11) were detected in patients also hosting HCM-associated myofilament mutations.
The missense mutation, W4R-MLP, which localizes to telethonin's binding domain, was noted in 7 patients (cases 1-7) . Three of these patients (cases 5-7) also had a mutation involving either the beta myosin heavy chain or myosin binding protein C.
W4R was also observed in one of the 400 reference alleles examined (a healthy Caucasian control).
HCM-associated TCAP mutations
Three different, novel TCAP mutations were identified in 4 patients with HCM ( Table 2, cases 13 -16). Two patients (cases 13 and 14) had an in-frame deletion involving glutamic acid at position 13 (E13del). The R70W mutation was located in the reciprocal MLP-binding domain of telethonin in a patient (case 15) with a MLVWT of 46 mm and a positive family history for HCM. The titin-binding domain of telethonin was host to a missense mutation, P90L, for one patient (case 16) who also had a missense mutation involving myosin binding protein C.
Genotype-phenotype relationships in MLP/TCAP-HCM
Compared to patients still lacking a mutation (genotype negative) and patients with myofilament-HCM, patients with mutations involving either MLP or TCAP more closely resembled the subset with myofilament-HCM (Figure 3 a- Genotyped patients with hypertrophic cardiomyopathy are grouped on the X-axis as hosting as hosting no putative mutation (genotype negative), hosting a myofilament mutation (myofilament-HCM), a MLPmutation or a TCAP-mutation. Unless otherwise noted, all pair wise comparisons are not statistically significant. *, p<0.05 compared to all other groups
Discussion
As critical components of the dynamic protein scaffolding between the sarcomere and cytoskeleton at the Z-line, the titin-muscle LIM protein-telethonin complex is involved in both cyto-architecture and mechano-signaling, thus serving as a potential link between myofilament-HCM and Z-disc-HCM. 1 Prior to this study, 1 HCM-associated mutation in titin [28] , 4 HCM-associated mutations in MLP [22, 31] and 2 HCM-associated mutations in telethonin have been reported [21] . In addition, consistent with the notion that HCM and DCM are often allelic disorders, several DCM-associated mutation in these 3 Z-disc proteins have been discovered as well [23, 24, 32, 33, 34] . Based upon our observations in this study, the genes encoding Z-disc proteins currently implicated so far as only DCM-susceptibility genes constitute rational candidate genes to explore in HCM.
This study represents the largest series of patients examined for the 3 known The pathogenic mechanism for HCM in these patients hosting both MLP variants and myofilament mutations may be due to synergistic heterozygosity (two-hit hypothesis) as we have previously demonstrated in a patient hosting a known myosin binding protein C missense mutation and a functionally-compromised frataxin mutation [35] . Previously, we demonstrated that among the 140 patients in our cohort previously established to have solely myofilament-HCM, 10 patients (7%) hosted 2 myofilament mutations with one of the variants usually involving myosin binding protein C [14] . Supporting the notion that both variants contributed to the expressed phenotype, these patients with multiple myofilament-HCM were younger at diagnosis and had greater hypertrophy than those having a single myofilament mutation. Herein, proportionately more patients with putative Z-disc-HCM also had a myofilament mutation raising the possibility that some of these variants may represent false positives. Future studies of the families represented by these HCM cases may shed light on the relative contributions of both the myofilament and the Z-disc mutation in the expressed phenotype.
The precise contribution of W4R-MLP (seen in 7 patients, cases 1-7) in the pathogenesis of HCM remains an enigma. Four of the 7 patients with W4R-MLP in the present study also have a published HCM-associated myofilament mutation. Initially, W4R was discovered as a DCM-associated mutation and was reportedly absent in 640 normal reference alleles [34] . Localizing to the telethonin-binding domain of MLP, it was not surprising to see in vitro assays demonstrating markedly reduced interaction/localization with telethonin [34] . Transgenic mouse models of W4R-MLP yield mice with a rather pronounced cardiomyopathy characterized by significant ventricular dilation and systolic dysfunction [36] .
Recently, W4R-MLP was observed in 1 of 137 unrelated patients with HCM [31] . This variant was found in a patient with predominant apical HCM in which no myofilament mutations were identified. However, these investigators also observed W4R in 3 of 500 reference alleles (0.6% allelic frequency). We have now observed 
